About TeleSkin
TeleSkin is a company based in Esbjerg (Denmark) founded in 2014. TeleSkin has raised $1.47 million across 3 funding rounds from investors including SEED Capital. The company has 1 employees as of December 31, 2021. TeleSkin operates in a competitive market with competitors including Castle Biosciences, DermTech, DermaSensor, MedLumics and SciBase, among others.
- Headquarter Esbjerg, Denmark
- Employees 1 as on 31 Dec, 2021
- Stage Minicorn
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Teleskin Aps
-
Annual Revenue
Not available
-
Net Profit
-$12.83 K (USD)11as on Dec 31, 2021
-
EBITDA
-$12.83 K (USD)11as on Dec 31, 2021
-
Total Equity Funding
$1.47 M (USD)
in 3 rounds
-
Latest Funding Round
$251.86 K (USD), Seed
May 24, 2016
- Investors
-
Employee Count
1
as on Dec 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of TeleSkin
TeleSkin has successfully raised a total of $1.47M across 3 strategic funding rounds. The most recent funding activity was a Seed round of $251.86 thousand completed in May 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in TeleSkin
TeleSkin has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include SEED Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm backing Nordic tech startups from seed to Series A with investments in Consumer, Deep Tech, and related sectors.
|
Locked | Locked | Locked |
Investor details for TeleSkin
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by TeleSkin
Investment portfolio details for TeleSkin
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - TeleSkin
Detailed financials for TeleSkin
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Teleskin Comparisons
Peer comparison for TeleSkin
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of TeleSkin
TeleSkin operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Castle Biosciences, DermTech, DermaSensor, MedLumics and SciBase, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Precision diagnostic and prognostic tests are developed by Castle Biosciences.
|
|
| Locked | Locked | Locked |
Adhesive patch biopsies for skin cancer detection are provided.
|
|
| Locked | Locked | Locked |
Handheld diagnostic device for skin cancer lesions is developed.
|
|
| Locked | Locked | Locked |
Biological tissue imaging is developed using optical coherence tomography.
|
|
| Locked | Locked | Locked |
Point-of-care device for malignant melanoma detection is provided.
|
|
| Locked | Locked | Locked |
Online platform to keep track of skin cancer
|
Detailed competitors of TeleSkin
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Teleskin
Complete news archive for TeleSkin
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about TeleSkin
TeleSkin was founded in 2014.
TeleSkin is headquartered in Esbjerg, Denmark.
TeleSkin is a funded company, having raised a total of $1.47M across 3 funding rounds to date.
As of Dec 31, 2021, the latest employee count at TeleSkin is 1.
TeleSkin was founded in 2014 in Esbjerg, Denmark, as a health technology company. A mobile application is provided to identify atypical moles and monitor changes over time. Awareness of melanoma and other skin diseases is raised through mole tracking features. Premium services allow scans to be compared for detecting alterations. Operations focus on early detection in the dermatology sector.
TeleSkin's top competitors include DermTech, DermaSensor and AMLo Biosciences.
TeleSkin has 1 investor. Key investors include SEED Capital.
The valuation of TeleSkin is $3.41M as of May 2016.